|
Volumn 5, Issue 8, 2006, Pages 621-
|
Budget cuts curb Europe's enthusiasm to revive innovation
a
a
NONE
|
Author keywords
[No Author keywords available]
|
Indexed keywords
BIOLOGICAL MARKER;
ALZHEIMER DISEASE;
BUDGET;
CLINICAL RESEARCH;
CONSENSUS DEVELOPMENT;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG RESEARCH;
DRUG SAFETY;
EUROPE;
FINANCIAL MANAGEMENT;
FUNDING;
HEALTH EDUCATION;
KNOWLEDGE MANAGEMENT;
NOTE;
PREDICTION;
PRIORITY JOURNAL;
TOXICOGENETICS;
BUDGETS;
DRUG DESIGN;
EUROPE;
|
EID: 33746585368
PISSN: 14741776
EISSN: 14741784
Source Type: Journal
DOI: 10.1038/nrd2122 Document Type: Note |
Times cited : (1)
|
References (0)
|